Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.
Dr. David Oh is a medical oncologist who cares for patients who are receiving novel immunotherapies for cancers as part of clinical trials. These are treatments that harness the patient's own immune system to fight cancer.
This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.